✕
NEWS
Home
NEWS
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
All
MauriceHampsink
14 oktober 2019
14 oktober 2019
Xenikos receives FDA Fast Track designation for T-Guard® for treating steroid-refractory acute graft-versus-host disease
11 juni 2019
11 juni 2019
Xenikos announces IND clearance by the FDA for a pivotal Phase 3 trial using T-Guard® for treating steroid-refractory acute GVHD
20 december 2018
20 december 2018
Xenikos partners with the BMT CTN to conduct a U.S.-based Phase 3 trial to test T-Guard® in aGVHD
Load more